Patterns of Rectal Cancer Radiotherapy Adopting Evidence-Based Medicine: An Analysis of the National Database from 2005 to 2016
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose Not many studies have evaluated the adoption and dissemination of evidence-based medicine in rectal cancer radiotherapy (RT). We aimed to analyze the differences by institutional characteristics and geography in adopting evidence-based care for rectal cancer RT and factors affecting the adoption in Korea. Materials and Methods Korean National Health Insurance Service claims database was used. All rectal cancer patients treated with radical surgery and adjuvant RT at the same institution in 2005-2016 were included in this study. RT within 3 months before and after surgery was regarded as preoperative and postoperative RT, respectively. Results A total of 16,827 patients treated in 83 institutions were included in the analysis. The use of preoperative RT has substantially increased over time, from 40.6% in 2005 to 84.2% in 2016 all over the nation. The proportion of preoperative RT (54.8%) exceeded that of postoperative RT (45.2%) in 2006. However, a wide range of institutional and regional variation was observed. Compared to high-volume institutions, low-volume institutions showed late adoption and variable dissemination patterns of preoperative RT. Busan–Ulsan–Gyeongsangnam- do and Gangwon-do showed slower adoption and less use of preoperative RT than other region. Conclusion We demonstrated gradual and steady increase in adoption of preoperative RT in rectal cancer treatment nationally from 2005 to 2016. Institutional variations between high- and lowvolume institutions were observed.
Abstract
Purpose Not many studies have evaluated the adoption and dissemination of evidence-based medicine in rectal cancer radiotherapy (RT). We aimed to analyze the differences by institutional characteristics and geography in adopting evidence-based care for rectal cancer RT and factors affecting the adoption in Korea. Materials and Methods Korean National Health Insurance Service claims database was used. All rectal cancer patients treated with radical surgery and adjuvant RT at the same institution in 2005-2016 were included in this study. RT within 3 months before and after surgery was regarded as preoperative and postoperative RT, respectively. Results A total of 16,827 patients treated in 83 institutions were included in the analysis. The use of preoperative RT has substantially increased over time, from 40.6% in 2005 to 84.2% in 2016 all over the nation. The proportion of preoperative RT (54.8%) exceeded that of postoperative RT (45.2%) in 2006. However, a wide range of institutional and regional variation was observed. Compared to high-volume institutions, low-volume institutions showed late adoption and variable dissemination patterns of preoperative RT. Busan–Ulsan–Gyeongsangnam- do and Gangwon-do showed slower adoption and less use of preoperative RT than other region. Conclusion We demonstrated gradual and steady increase in adoption of preoperative RT in rectal cancer treatment nationally from 2005 to 2016. Institutional variations between high- and lowvolume institutions were observed.
참고문헌 (13)
- Gastrointestinal Tumor Study Group, "Prolongation of the disease-free interval in surgically treated rectal carcinoma", N Engl J Med, 312, pp.1465~1472 (1985)[DOI]
- Krook JE, "Effective surgical adjuvant therapy for highrisk rectal carcinoma", N Engl J Med, 324, pp.709~715 (1991)[DOI]
- Fitzgerald TL, "Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice", World J Surg, 37, pp.639~645 (2013)[DOI]
- Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer", N Engl J Med, 351, pp.1731~1740 (2004)[DOI]
- Koperny M, "The Cochrane collaboration: the role in the evolution of evidence-based medicine and development of cooperation in Poland", Przegl Epidemiol, 70, pp.508~520 (2016)
- Reddy SS, "Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies", World J Gastrointest Surg, 9, pp.97~102 (2017)[DOI]
- Murphy CC, "Patterns of colorectal cancer care in the United States: 1990-2010", J Natl Cancer Inst, 107, pp.djv198~ (2015)
- Kwon S, "Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage", Health Policy Plan, 24, pp.63~71 (2009)
- 기영준, "Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study", Cancer Research and Treatment, 49(1), pp.29~36 (2017), 대한암학회
- Sheldon TA, "Getting research findings into practice. When to act on the evidence", BMJ, 317, pp.139~142 (1998)[DOI]
- Shiffman RN, "The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation", BMC Med Inform Decis Mak, 5, pp.23~ (2005)[DOI]
- [URL]
- Stewart DB, "Rectal cancer and teaching hospitals: hospital teaching status affects use of neoadjuvant radiation and survival for rectal cancer patients", Ann Surg Oncol, 20, pp.1156~1163 (2013)[DOI]